Get started

Beyondtechnicalanalysis

BREAKOUT - VA TECH WABAG LTDBUY - WABAG CMP - Rs. 354 Target - 1: Rs. 515 Target - 2: Rs. 710 . . Technical - 1) Trendline BO 2) Cup and Handle(nearing BO). . . Fundamentals - 1) VA Tech Wabag Limited (NSE:WABAG) is considered a reasonable investment option due to its current share price increase of over 10%. Its price-to-earnings ratio of 12.34x is lower than its industry peers’ ratio of 13.03x, indicating a fair valuation. 2) Additionally, the company is expected to see a profit growth of 42% in the next two years, which is encouraging. . . Follow me for more!
NLong
by nilakshgupta
LIST OF MONOPOLY AND DUOPOLY STOCKS by businessHi guys, Upto i know these are some of the monopolys and duopoly stocks which occupy significant market share if you also know some companys please share some companies exactly are not monopolys but have a unique product or some edge in market however some of these companies already valued at high p/e and usually they always stay at that p/e due to monopoly or duopoly status please do your own reaseach in which fields they are monopolys and duopolys 1.mcx 2.reliance 3.airtel 4.iex 5.power grid-only grid 6.coal india 7.nhpc 8.bse 9.tatacoffee 10.indo borax and chemicals 11.pidilite 12.mcdowell 13.radicokaithan 14.cdsl 15.gravita india 16.granules india 17.cams 18.hawkins cookers 19.ashok leyland 20.irctc 21.ccl products 22.asian paints 23.berger paints 24.vesuvius india 25.upl 26.grindwell nortan 27.itc 28.hul 29.ttk prestige 30.adani ports 31.colgate-colpal 32.kaveri seeds 33.sswl 34.carborundum universal 35.jamna auto ind 36.RHIM 37.titan 38.k fin technologies disclaimer- this is not any investment call or idea , this just my view and it can go wrong ,this is only for educational purposes trade at your own risk :)
NSE:MCX
by techno_funda_guy
RATTANINDIA ENT - 180% RETURNS!!!BUY - RATTANINDIA ENTERPRISES LTD CMP - Rs. 38 Target - 1: Rs. 47 Target - 2: Rs. 67 Target - 3: Rs. 105 . . Technicals - 1) Bullish Symmetrical Triangle - nearing BO . . Fundamentals - SWOT Analysis - 1) Strengths: Consistent Highest Return Stocks over Five Years - Nifty500 Stocks with improving cash flow, with good durability (subscription) Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year Efficient in managing Assets to generate Profits - ROA improving since last 2 year Growth in Quarterly Net Profit with increasing Profit Margin (YoY) Company with Low Debt Annual Net Profits improving for the last 2 years FII / FPI or Institutions increasing their shareholding . 2) Weaknesses: Promoters increased pledged shares QoQ A decline in Quarterly Net Profit (YoY) Decline in Net Profit with falling Profit Margin (QoQ) High promoter stock pledges The highest increase in pledges by promoters . 3) Opportunities: Undervalued Growth Stocks Insiders bought stocks . 4) Threats - Red Flag: Large Swings Between Profit and Loss . . This is just a view, please trade at your own risk. . . Follow me for more!
NSE:RTNINDIALong
by nilakshgupta
DB REALTY - 175% RETURNS!!!BUY - DB REALTY LTD CMP - Rs. 90 Target - 1: Rs. 160 Target - 2: Rs. 245 . . Technical Analysis - Cup and Handle Pattern . . Fundamentals - 1) DB Realty, founded in 2007, is a Mumbai-based real estate company that operates in the residential, commercial, and hospitality sectors. The company has developed several high-end residential and commercial properties in Mumbai, including Orchid Heights, Orchid Woods, and Orchid Crown. DB Realty has also ventured into the hospitality sector by launching the Hilton Hotel in Mumbai. 2) In terms of financial performance, DB Realty reported a consolidated revenue of Rs. 1,045.5 crores for the fiscal year 2020-2021, which is a decrease of 34.5% from the previous year. The company reported a net profit of Rs. 8.3 crores for the same period, which is a significant improvement from the previous year's net loss of Rs. 224.3 crores. The company's debt-to-equity ratio stood at 0.87, indicating that the company has a higher debt component in its capital structure. 3) DB Realty's business model relies heavily on project-dependent revenues. This means that the company generates most of its revenue from selling properties under development. As a result, the company's financial performance is highly dependent on the timely completion and sale of its projects. Additionally, the real estate industry is highly cyclical, and the demand for properties is subject to macroeconomic factors such as interest rates, inflation, and economic growth. 4) In terms of future prospects, DB Realty plans to launch several new projects in Mumbai, including a luxury residential project in Bandra and a commercial project in Andheri. The company has also announced plans to expand its hospitality business by launching new hotels in Mumbai and other major cities in India. 5) Overall, while DB Realty has a strong presence in the Mumbai real estate market and has shown improvement in its financial performance, it faces significant challenges in terms of legal and regulatory issues and the cyclical nature of the real estate industry. Investors should carefully evaluate these factors before making any investment decisions. . . Follow me for more!
NSE:DBREALTYLong
by nilakshgupta
DCB BANK - IN DEPTH ANALYSISBUY - DCB BANK LTD CMP - Rs. 100 Target - 1: Rs. 123 Target - 2: Rs. 140 Target - 3: Rs. 160 . . Technicals - 1) Bullish Flag Pattern (Before Breakout) . . Fundamentals - DCB Bank Limited (NSE:DCBBANK) is a scheduled commercial bank that provides a range of banking and financial services to its customers. The bank operates in India and has a strong presence in the states of Maharashtra, Gujarat, Andhra Pradesh, and Karnataka. 1) Financial Performance: DCB Bank's financial performance has been consistently improving over the past few years. Its revenue grew at a CAGR of 13.6% from FY2017 to FY2021. However, the bank's profitability has been inconsistent, with net profit declining by 22.3% in FY2020 before recovering by 31.8% in FY2021. The bank's Return on Equity (ROE) has also been inconsistent, with a low of 4.2% in FY2020, and a high of 10.5% in FY2019. In Q3FY22, DCB Bank's net profit grew by 41% YoY and NII by 14% YoY. 2) Asset Quality: DCB Bank has maintained a relatively healthy asset quality, with gross non-performing assets (GNPA) ratio of 1.84% and net non-performing assets (NNPA) ratio of 0.54% as of December 31, 2021. The bank has also been proactive in recognizing and providing for bad loans. Its provision coverage ratio (PCR) stood at 83.84% as of December 31, 2021. 3) Capital Adequacy: DCB Bank has maintained a healthy capital adequacy ratio (CAR), which stood at 15.29% as of December 31, 2021. The bank has been raising capital through various means, including QIPs and the issuance of Tier-II bonds, to support its growth plans. 4) Valuation: DCB Bank is currently trading at a price-to-earnings (P/E) ratio of 21.7x, which is higher than the industry average of 16.7x. The bank's price-to-book (P/B) ratio of 1.7x is also higher than the industry average of 1.5x. However, the bank's dividend yield of 1.5% is higher than the industry average of 1.3%. 5) Growth prospects: DCB Bank has been expanding its branch network and digital capabilities to drive growth. The bank has a total of 345 branches and plans to add 20-25 new branches every year. The bank has also been focusing on building its digital capabilities and has launched various initiatives such as mobile banking, internet banking, and digital lending. The bank has set a target of achieving 25% of its total loans through digital channels by FY2024. In conclusion, DCB Bank has maintained healthy asset quality and capital adequacy and has been expanding its branch network and digital capabilities to drive growth. However, the bank's profitability has been inconsistent, and its valuations are higher than the industry average. Investors should keep these factors in mind before making an investment decision in DCB Bank. . . Follow me for more!
NSE:DCBBANKLong
by nilakshgupta
BankNifty Future Analysis for Today 1st June 2023BankNifty Future Analysis for Today 1st June 2023 As per our #analysis for #BankNiftyFuture, we are expecting these Intraday levels today, kindly check the charts on 15 min time frame and act accordingly. #IntradayLevels Disclaimer : All the provided levels are for #educational purpose only, please do your own analysis before doing any trade in the live market or consult your #financial advisor before act. Follow Us For More #Updates in Future
NSE:BANKNIFTY1!
by MarkitVUE
ADVANCED ENZYME TECH - 105% RETURNS!!!BUY - ADVANCED ENZYME TECHNOLOGY LTD CMP - Rs. 289 Target - 1: Rs. 385 Target - 2: Rs. 475 Target - 3: Rs. 590 . . Technicals - Cup and Handle Pattern . Fundamentals - Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes. 1) The company is almost debt free. 2) The company has been maintaining a healthy dividend payout of 19.5%. . A) Market Position - The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. . B) Product Portfolio - The company manufactures and markets over 400+ proprietary products developed from 68+ enzymes and probiotics. It has approx 13 patents in its name. . C) International Presence - The Co. is present in more than 45 countries in the world and caters to more than 700 customers worldwide. The geographic split for FY22 is as follows: India - 44% Americas - 40% Europe - 6% Asia (Excluding India) - 7% Rest of the World - 3% . D) Business Segments - Human Healthcare (68% of revenues) The company provides proprietary enzyme products and customized enzyme solutions to various pharmaceutical and nutraceutical companies in India, North America, Asia (ex-India), Europe, and other countries globally. Animal Nutrition (11% of revenues) It provides enzyme-based feed additives for the animal nutrition industry, mainly catering to poultry and swine. Animal Nutrition product offering enables animals to maximize the nutrients they absorb from the feed which helps the customers to reduce the feed costs. Industrial Bioprocessing (12% of revenues) The company produces non-food processing enzymes for various industries such as textiles, leather, detergent, and pulp & paper, which are used in the manufacturing of a wide range of products. It also produces food processing enzymes which are essential for enhancing food and beverage products. Specialized Manufacturing (9% of revenues) In this segment, the Co. manufactures products based on effervescent technology. These effervescent products extend solutions in Nutraceutical, Pharmaceutical, Bakery, Washing solutions, and other Speciality products. . . This is just a view by an expert analyst, please invest at your own risk. . Follow me for more!
NSE:ADVENZYMESLong
by nilakshgupta